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ABSTRACT
Discriminating lung nodules as malignant or benign is still
an underlying challenge. To address this challenge, radiol-
ogists need computer aided diagnosis (CAD) systems which
can assist in learning discriminative imaging features corre-
sponding to malignant and benign nodules. However, learn-
ing highly discriminative imaging features is an open prob-
lem. In this paper, our aim is to learn the most discriminative
features pertaining to lung nodules by using an adversarial
learning methodology. Specifically, we propose to use un-
supervised learning with Deep Convolutional-Generative Ad-
versarial Networks (DC-GANs) to generate lung nodule sam-
ples realistically. We hypothesize that imaging features of
lung nodules will be discriminative if it is hard to differen-
tiate them (fake) from real (true) nodules. To test this hy-
pothesis, we present Visual Turing tests to two radiologists in
order to evaluate the quality of the generated (fake) nodules.
Extensive comparisons are performed in discerning real, gen-
erated, benign, and malignant nodules. This experimental set
up allows us to validate the overall quality of the generated
nodules, which can then be used to (1) improve diagnostic
decisions by mining highly discriminative imaging features,
(2) train radiologists for educational purposes, and (3) gener-
ate realistic samples to train deep networks with big data.
Index Terms— Lung nodules, Generated samples, Visual
Turing Test, Computed Tomography (CT), Deep learning,
Generative Adversarial Networks (GANs), Computer Aided
Diagnosis (CAD) systems
1. INTRODUCTION
The primary cause of mortality today is cancer and annually
it causes approximately 8.2 million deaths. In comparison to
all cancers, lung cancer is the most lethal, as it causes roughly
1.59 million deaths per year [1].
Low dose computed tomography (CT) scans aid radiolo-
gists in screening lung cancer and can help early diagnosis as
well. CT scans have the potential to save millions of lives if
they are properly observed and interpreted in the early stages
of lung cancer. One major challenge in automatic detection
and classification of lung cancer is the variability in the ap-
pearance of lung nodules. Lung nodules are found in distinct
shapes, sizes, intensities, locations, and other characteristics,
regardless of being malignant or benign. Due to these charac-
teristics, radiographic analysis of lung nodules can lead to an
under or over diagnosis. Misinterpretation in this regard can
lead to unnecessary surgeries and misdiagnoses.
Computer-Aided Diagnosis (CAD) systems help in iden-
tifying discriminative features associated with malignant and
benign lung nodules. Previous contributions by Hussein et
al. have shown the effectiveness of supervised learning tech-
niques for lung nodule classification. In their work, sagittal,
axial, and coronal 2D patches of a CT scan are put into a
2D-Convolutional Neural Network (CNN) [2]. Extending this
idea, Hussein et al. used supervised learning methodologies
by fine-tuning a 3D-CNN on a visual dataset and by using
multitask learning techniques to focus on specific attributes
such as calcification, lobulation, sphericity, speculation, mar-
gin, and texture [3].
Recent works by Goodfellow et al. proposed Genera-
tive Adversarial Networks (GANs), a new framework that
can learn discriminative features from images and generate
realistic samples [4]. Kamnitsas et al. further investigated
this framework to learn domain invariant features for unsu-
pervised automatic brain lesion segmentation [5]. In a simi-
lar fashion, Schlegl et al. proposed AnoGANs to aid in the
unsupervised detection of abnormalities in diseases found in
imaging data. Their results showed that detecting anomalies,
such as retinal fluid and hyper-reflective foci in brain tumors
is now a possibility [6]. These related works in the realm
of both supervised and unsupervised learning, show that ad-
vanced machine learning methods, particularly deep learning
and GANS, have made new enlightening discoveries in the
medical imaging field.
Specific to recent developments both in lung cancer
screening and machine learning, our contributions in this
study are the following: (1) We generate realistic lung nod-
ules using GAN for the first time in the literature. Briefly,
the presented GAN framework includes a generator which
maps samples from an arbitrary latent distribution to data,
and an adversarial discriminator that tries to distinguish be-
tween real and generated samples as accurately as possible.
While the generator’s goal is to ”fool” the discriminator by
producing samples which are as close to real data as pos-
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Fig. 1. The DC-GAN architecture used for generating lung nodule samples. The generator consists of 3 convolutional layers
and generates a 56 by 56 image sample. The discriminator, on the other hand, consists of 2 convolutional layers and takes a real
and the generated image sample and outputs a probability score, which denotes whether the given images are real or generated.
sible, the discriminator’s role is to learn the most powerful
features in order not to be deceived. (2) We perform various
Visual Turing tests with radiologists to qualitatively evaluate
the generated samples and to determine the success of our
approach. (3) Class-specific nodules (benign or malignant)
are generated. We quantitatively measure the inter-observer
variations, False Recognition Rate (FRR), and True Recog-
nition Rate (TRR) to compute the goodness of the generated
examples.
We believe that generating high-quality lung nodules sim-
ilar to the original (real) ones is of high importance for several
reasons. Throughout our experiments, we generated samples
for benign only, malignant only, and a mixture of both types.
These generated images allow us to discern features specific
to malignant and benign nodules, which could lead to better
diagnosis, train radiology residents, and model complex deep
learning classifiers. To verify that our samples are similar to
the original samples, we conduct a Visual Turing test. Our ob-
jective is to convince radiologists that our generated samples
are actually the original samples. This will give us qualitative
and quantitative measures to evaluate our generated nodules.
2. MATERIALS AND METHODS
We use the publicly available lung nodule dataset, the Lung
Image Database Consortium image collection (LIDC-IDRI) [7],
for our experiments. This dataset contains 1018 lung cancer
screening thoracic CT scans with annotations and malignancy
ratings, where a rating of 1 denotes low malignancy and a rat-
ing of 5 represents high malignancy. Lung nodules that are
of diameters greater than or equal to 3 mm were annotated
by at most 4 radiologists. Nodules that were annotated by
at least 3 radiologists are selected and nodules with a malig-
nancy rating of 3 are excluded from selection to avoid high
uncertainty. The final dataset used in this experiment consists
of 1145 nodules; 635 are benign and 510 are malignant.
2.1. Network Architecture
Due to deep learning advances, technologies have the abil-
ity to meet almost the same level of image understanding
as human beings. Specifically, GANs have been shown to
produce exceptional results in this regard. To generate high-
quality nodules, we propose to use Deep Convolutional Gen-
erative Adversarial Networks (DC-GANs). DC-GANs follow
the same concept as the original GAN, which is composed
of a generator G and a discriminator D. Random noise is
put into the generator and it generates a sample image. The
objective is to eventually learn a distribution pz from this ran-
dom noise. The goal for the generator is to generate samples,
so as to deceive the discriminator as being original samples.
The discriminator, then, classifies the original samples, which
come from the pdata distribution, and the generated samples,
as fake or real. The discriminator and generator play a min-
max game represented by the following value function:
min
G
max
D
V (D,G) = Ex∼pdata(x)[log(D(x))]
+Ez∼pz(z)[log(1−D(G(z)))]
(1)
DC-GANs augment the performance of the standard GAN
by using convolutional layers along with batch normalization,
removing fully connected layers, and utilizing ReLU, leaky
ReLU, and tanh activation functions [8]. The architecture for
the proposed experiments in this paper, shown in Figure 1
uses a generator comprised of 3 convolutional layers with
Fig. 2. Generated low-quality (red) and high-quality (green) samples of lung nodules using a DC-GAN. In comparison with the
low quality nodules, the high-quality nodules are more well-formed and defined.
Fig. 3. On the left (red), nodules 1-18 are generated by a DC-GAN and 19-36 are real malignant nodules. On the right (green),
nodules 1-18 are generated by a DC-GAN and 19-36 are real benign nodules. Nodule numbering is from left to right.
batch normalization and a tanh activation function applied to
the last layer. The discriminator includes 2 deconvolutional
layers with leaky ReLU and a 3136-dimensional fully con-
nected layer with a sigmoid activation function.
We train the network to generate benign, malignant sam-
ples as well as a mixture of both malignant and benign sam-
ples. A batch size of 64 is used along with a learning rate of
.0001 and .0002 for the discriminator and the generator. The
network is trained for benign samples until 114,000 iterations,
malignant samples until 110,000 iterations, and a mixture of
malignant and benign samples until 99,000 iterations. There
was no further improvement in the image quality after these
numbers of iterations. Instead, the image quality started de-
grading, so we concluded those as our early stopping points
for training.
2.2. Visual Turing Test
To compare the generated nodules with original nodules we
propose 18 Visual Turing experiments. Our experiments were
conducted with two radiologists, where radiologist 1 had 13
years of experience and radiologist 2 had 4 years of experi-
ence reading lung cancer scans. We conducted these set of
experiments for benign, malignant, and a mixture of both be-
nign and malignant nodules with both radiologists in radiol-
ogy rooms to fully evaluate their perception of both real and
generated nodules. Both radiologists were blinded of each
other’s evaluation of experiments and were not shown real or
generated samples prior to experiments. Each Visual Turing
experiment contains distinct 36 high-quality sampled gener-
ated nodules positioned in a 6 by 6 square grid; both radi-
ologists were allowed to zoom or change the viewpoint of
the image. Visuals did not contain patient information, back-
ground, or symptoms; only lung nodules from CT images
were presented. CT images used were from the LIDC-IDRI
dataset and were not prepared by the two radiologists who
participated in our Visual Turing test. Anisotropic diffusion
(Perona-Malik diffusion), which is a conventional noise re-
moval filtering, was applied to images without distorting edge
information while removing noise for better visualization [9].
For each experiment of all generated nodules, all real nod-
ules, and a mixture of generated nodules, we inform radiolo-
gists that the presented screen can contain anything (all real,
all fake, or mixture). The proposed questions for radiologists
were as follow:
• Experiments 1, 2, 3, 16, 17, 18 (All Nodules): If there is
any, identify which nodule(s) are generated, which one(s)
are real?
• Experiments 4, 5, 6, 13, 14, 15 (Benign Nodules): If there
is any, identify which nodule(s) are generated, which one(s)
are real? Furthermore, identify which nodule(s) are benign
if there is any.
• Experiments 7, 8, 9, 10, 11, 12 (Malignant Nodules): If
there is any, identify which nodule(s) are generated, which
one(s) are real? Furthermore, identify which nodule(s) are
malignant if there is any.
3. RESULTS
For our visual inspection and comparison we gather low-
quality lung nodules along with high-quality samples as
shown in Figure 2. Moreover, for our Visual Turing test,
we also generated class-specific nodules and compared them
with original nodules shown in Figure 3. Lung nodule gen-
erated samples in both Figure 2 and 3 all have anisotropic
diffusion applied. To quantitatively measure our generated
nodules, we calculate False Recognition Rate (FRR), shown
Fig. 4. The experiments above were used to calculate the FRR for the two radiologists and contain either all generated nodules or
a mixture of real and generated nodules. The FRR shown in the pie charts indicate the percentage of nodules which radiologists
recognized as generated (fake). E2, E5, E8, E11, E14, and E17 were excluded, since they contain all real nodules, hence they
do not have results about fake or real lung nodule differences, but they do have results for malignant and benign lung nodules.
Fig. 5. Radiologists’ inter-observer variation for the respec-
tive cases of malignant/benign for the 36 samples within the
experiments 4-9 and 13-18 and real/generated for the experi-
ments 1-18.
in Figure 4, and True Recognition Rate (TRR) of two radiolo-
gists’ blinded evaluations of the experiments. FRR calculates
the percentage of fake nodules recognized as fake by the
radiologist whereas TRR calculates the percentage of real
nodules recognized as real.
The FRR results show that we successfully convinced ra-
diologist 1 that several of our generated nodules were real for
67% of our experiments and radiologist 2 for 100% of our ex-
periments. Since radiologists face numerous challenges while
classifying nodules, we also decided to investigate their TRR.
Radiologist 1 had a mean TRR of 58.56% while radiologist
2 had captured more true ones (93.52%). To remain unbi-
ased, we calculated radiologists’ inter-observer variation, as
summarized in Figure 5, throughout experiments for malig-
nant and benign nodules, as well as for real and generated
nodules. Both radiologists had a mean inter-observer agree-
ment for malignant and benign cases of 58.56% and for real
and generated cases of 44.91%. These statistics indicate that
the presented algorithm has the capability of generating high-
quality lung nodules. These statistics also show that radiolo-
gists failed to distinguish between malignant and benign nod-
ules accordingly. This performance can be ascribed to the
successful generation of realistic images using the DC-GAN
architecture.
4. DISCUSSION & CONCLUSION
In this work, we generated realistic lung nodule samples using
a DC-GAN architecture for the first time. The generated sam-
ples did manage to deceive radiologists in our experiments.
The generated samples, however, do present limitations. One
major limitation is that the features from both malignant and
benign nodules could be present in a generated sample. This
could ultimately cause difficulty in interpreting visualization
for radiologists. Also, our generated samples would bene-
fit from further improvement in terms of quality and varia-
tion. The results from our proposed experiments will help us
readjust parameters and develop a more robust architecture
for future experiments that can generate a larger number of
high-quality realistic generated (fake) samples.
As future work, we also aim to expand our experimental
setup by including more radiologists and experts. We will
also explore image generation in the 3D space as CT scans are
inherently volumetric. The use of a 3D network could bring
in important volumetric information which would otherwise
be lost in 2D image slices.
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